Investor Relations

Latest Financial Results

Oct 24, 2024 • 4:05 PM EDT

Q1 2025 Quarterly Results

Quarter Ended Sep 30, 2024

Earnings Release PDF
Earnings Webcast Transcript
Presentation
Corporate 1-Pager
10-Q PDF
XBRL

Stock Snapshot

Press Releases

View all news

Latest Presentation

1Q25 Earnings Presentation

View All Presentations

Upcoming Event

UBS Global Healthcare Conference

Add to Calendar View All Events

Company Overview

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

View Executive Team View Board of Directors

Latest Financial Results

Q1 2025

Quarter Ended Sep 30, 2024

Latest Annual Filing

For Fiscal Year Ending Jun 30, 2024

Report Links

Latest Sustainability Report

For Fiscal Year Ending Jun 30, 2023

View Report

IR Contacts

Headquarters

ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123

Investor Relations

ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123
T: 858-836-5971
InvestorRelations@resmed.com

Transfer Agent

Computershare, Inc.
PO Box 30170
College Station, TX 77842
USA
T: 800-962-4284
https://www.computershare.com/us

Computershare, Inc.
Level 3
60 Carrington Street
Sydney NSW 2000
Australia
T: +61 2 8234 5000
https://www.computershare.com/au